FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313891440> ?p ?o ?g. }

• W4313891440 endingPage "1112" @default.
• W4313891440 startingPage "1112" @default.
• W4313891440 abstract "Coronary heart disease (CHD), one of the leading causes of disability and death worldwide, is a multifactorial disease whose early diagnosis is demanding. Thus, biomarkers predicting the occurrence of this pathology are of great importance from a clinical and therapeutic standpoint. By means of a pilot study on peripheral blood cells (PBMCs) of subjects with no coronary lesions (CTR; n = 2) and patients with stable CAD (CAD; n = 2), we revealed 61 differentially methylated regions (DMRs) (18 promoter regions, 24 genes and 19 CpG islands) and 14.997 differentially methylated single CpG sites (DMCs) in CAD patients. MiRNA-seq results displayed a peculiar miRNAs profile in CAD patients with 18 upregulated and 32 downregulated miRNAs (FC ≥ ±1.5, p ≤ 0.05). An integrated analysis of genome-wide DNA methylation and miRNA-seq results indicated a significant downregulation of hsa-miR-200c-3p (FCCAD = −2.97, p ≤ 0.05) associated to the hypermethylation of two sites (genomic coordinates: chr12:7073122-7073122 and chr12:7072599-7072599) located intragenic to the miR-200c/141 genomic locus (encoding hsa-miR-200c-3p) (p-value = 0.009) in CAD patients. We extended the hsa-miR-200c-3p expression study in a larger cohort (CAD = 72, CTR = 24), confirming its reduced expression level in CAD patients (FCCAD = −2; p = 0.02). However, when we analyzed the methylation status of the two CpG sites in the same cohort, we failed to identify significant differences. A ROC curve analysis showed good performance of hsa-miR-200c-3p expression level (AUC = 0.65; p = 0.02) in distinguishing CAD from CTR. Moreover, we found a significant positive correlation between hsa-miR-200c-3p expression and creatinine clearance (R2 = 0.212, p < 0.005, Pearson r = 0.461) in CAD patients. Finally, a phenotypic correlation performed in the CAD group revealed lower hsa-miR-200c-3p expression levels in CAD patients affected by dyslipidemia (+DLP, n = 58) (p < 0.01). These results indicate hsa-miR-200c-3p as potential epi-biomarker for the diagnosis and clinical progression of CAD and highlight the importance of deeper studies on the expression of this miRNA to understand its functional role in coronary artery disease development." @default.
• W4313891440 created "2023-01-10" @default.
• W4313891440 creator A5004895617 @default.
• W4313891440 creator A5021687223 @default.
• W4313891440 creator A5050684931 @default.
• W4313891440 creator A5066656758 @default.
• W4313891440 creator A5067312687 @default.
• W4313891440 creator A5081928605 @default.
• W4313891440 creator A5086375346 @default.
• W4313891440 date "2023-01-06" @default.
• W4313891440 modified "2023-10-05" @default.
• W4313891440 title "Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease" @default.
• W4313891440 cites W1956069018 @default.
• W4313891440 cites W1983497588 @default.
• W4313891440 cites W1984689638 @default.
• W4313891440 cites W1988163167 @default.
• W4313891440 cites W2033102369 @default.
• W4313891440 cites W2036789134 @default.
• W4313891440 cites W2036943054 @default.
• W4313891440 cites W2041402229 @default.
• W4313891440 cites W2051430335 @default.
• W4313891440 cites W2052355316 @default.
• W4313891440 cites W2059357290 @default.
• W4313891440 cites W2059562857 @default.
• W4313891440 cites W2067738146 @default.
• W4313891440 cites W2085953797 @default.
• W4313891440 cites W2093478617 @default.
• W4313891440 cites W2104887076 @default.
• W4313891440 cites W2107195787 @default.
• W4313891440 cites W2112832510 @default.
• W4313891440 cites W2124296291 @default.
• W4313891440 cites W2126542964 @default.
• W4313891440 cites W2139362558 @default.
• W4313891440 cites W2143651952 @default.
• W4313891440 cites W2154381563 @default.
• W4313891440 cites W2174734928 @default.
• W4313891440 cites W2299400827 @default.
• W4313891440 cites W2319214713 @default.
• W4313891440 cites W2324841714 @default.
• W4313891440 cites W2470054393 @default.
• W4313891440 cites W2559373047 @default.
• W4313891440 cites W2580067419 @default.
• W4313891440 cites W2608588289 @default.
• W4313891440 cites W2616483624 @default.
• W4313891440 cites W2699220065 @default.
• W4313891440 cites W2735404270 @default.
• W4313891440 cites W2736829603 @default.
• W4313891440 cites W2775794168 @default.
• W4313891440 cites W2776680685 @default.
• W4313891440 cites W2782190825 @default.
• W4313891440 cites W2794333713 @default.
• W4313891440 cites W2944487182 @default.
• W4313891440 cites W2953804067 @default.
• W4313891440 cites W2963991899 @default.
• W4313891440 cites W2972084695 @default.
• W4313891440 cites W3006116566 @default.
• W4313891440 cites W3096247076 @default.
• W4313891440 cites W3104533492 @default.
• W4313891440 cites W3113178943 @default.
• W4313891440 cites W3147484503 @default.
• W4313891440 cites W3159710756 @default.
• W4313891440 cites W3175173658 @default.
• W4313891440 cites W3183857127 @default.
• W4313891440 cites W3184293131 @default.
• W4313891440 cites W3186661058 @default.
• W4313891440 cites W4210242902 @default.
• W4313891440 cites W4220823516 @default.
• W4313891440 cites W4224212301 @default.
• W4313891440 cites W4282923082 @default.
• W4313891440 cites W4282931909 @default.
• W4313891440 cites W4289261048 @default.
• W4313891440 doi "https://doi.org/10.3390/ijms24021112" @default.
• W4313891440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36674633" @default.
• W4313891440 hasPublicationYear "2023" @default.
• W4313891440 type Work @default.
• W4313891440 citedByCount "2" @default.
• W4313891440 countsByYear W43138914402023 @default.
• W4313891440 crossrefType "journal-article" @default.
• W4313891440 hasAuthorship W4313891440A5004895617 @default.
• W4313891440 hasAuthorship W4313891440A5021687223 @default.
• W4313891440 hasAuthorship W4313891440A5050684931 @default.
• W4313891440 hasAuthorship W4313891440A5066656758 @default.
• W4313891440 hasAuthorship W4313891440A5067312687 @default.
• W4313891440 hasAuthorship W4313891440A5081928605 @default.
• W4313891440 hasAuthorship W4313891440A5086375346 @default.
• W4313891440 hasBestOaLocation W43138914401 @default.
• W4313891440 hasConcept C104317684 @default.
• W4313891440 hasConcept C126322002 @default.
• W4313891440 hasConcept C127561419 @default.
• W4313891440 hasConcept C140173407 @default.
• W4313891440 hasConcept C143998085 @default.
• W4313891440 hasConcept C145059251 @default.
• W4313891440 hasConcept C150194340 @default.
• W4313891440 hasConcept C190727270 @default.
• W4313891440 hasConcept C2778096610 @default.
• W4313891440 hasConcept C2778213512 @default.
• W4313891440 hasConcept C2779018089 @default.
• W4313891440 hasConcept C2779134260 @default.

• next